News

Latest Press Releases

March 21, 2022

AnHeart Therapeutics Announces Presentation at the European Lung Cancer Congress (ELCC) 2022

March 1, 2022

AnHeart Therapeutics and Innovent Biologics Receive NMPA Breakthrough Designation for Taletrectinib in ROS1 Fusion-Positive Non-Small Cell Lung Cancer

January 25, 2022

AnHeart Therapeutics Appoints Prof. Andrés Cervantes to Scientific Advisory Board

More Press Releases

Latest News Articles

March 21, 2022
MedCity News

Precision oncology startup AnHeart Therapeutics co-founder shares cancer drug strategy

January, 10-12, 2022
Biotech Showcase

Outsmarting Cancer: Next Generation Therapies

December 16, 2021
Bioworld

Anheart Therapeutics raises $61M in series B for precision oncology pipeline

More News Articles

Media Contact

Kimberly Ha
KKH Advisors
917-291-5744
kimberly.ha@kkhadvisors.com